Literature DB >> 14652697

Diagnosis of neuroendocrine tumours by retrospective image fusion: is there a benefit?

H Amthauer1, J Ruf, M Böhmig, E Lopez-Hänninen, T Rohlfing, K-D Wernecke, U Plöckinger, M Gutberlet, A-J Lemke, T Steinmüller, B Wiedenmann, R Felix.   

Abstract

This study evaluated the use of image fusion in the preoperative staging of neuroendocrine tumors (NET) of the pancreas and the gastrointestinal tract (GIT). Thirty-eight patients suffering from a metastasized NET with location of the primary in the pancreas ( n=15) or the GIT ( n=23) were examined by somatostatin receptor scintigraphy (SRS) and computed tomography (CT). Consecutive image registration and fusion were performed using custom-built software integrated in AVS/Express (Advanced Visual Systems, Waltham, MA, USA). Registration was performed by a voxel-based algorithm based on normalized mutual information. Image fusion was feasible in 36/38 patients. A total of 87 foci were assigned to anatomical regions (e.g. gut, pancreas, liver, lymph node or others) by two independent observers in both SRS and SRS/CT fusion images. The assignments used a binary ranking system (1="definite", 0="not definite"). These results were then retrospectively compared to the classification of the foci, based on postoperative histology or clinical follow-up. Imaging by SRS allowed a definite anatomical assignment in 57% (50/87) and 61% (53/87) of all lesions in the case of observers A and B, respectively. Image fusion improved the topographic assignment to 91% (79/87) and to 93% (81/87). The number classified as "definite" by both observers increased from 54% (47/87) to 86% (77/87). The increase in definite assignments was highly significant for both observers ( P<0.0001 for each). In the case of foci classified as liver metastases, image fusion allowed improved assignment to the corresponding liver segment from 45% (18/40) to 98% (39/40) and from 58% (23/40) to 100% (40/40) by observers A and B, respectively. Furthermore, the improved assignment of foci classified as lesions by image fusion was relevant for therapy in 7/36 patients (19%). Therefore, the image fusion technique presented herein appears to be a very useful method for clinical routine.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14652697     DOI: 10.1007/s00259-003-1379-7

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  26 in total

Review 1.  Somatostatin receptor imaging, therapy and new strategies in patients with neuroendocrine tumours.

Authors:  G D Slooter; A Mearadji; W A Breeman; R L Marquet; M de Jong; E P Krenning; C H van Eijck
Journal:  Br J Surg       Date:  2001-01       Impact factor: 6.939

Review 2.  [The multimodal integration, correlation and fusion of morphology and function: the methods and initial clinical applications].

Authors:  G Wagenknecht; H J Kaiser; U Büll
Journal:  Rofo       Date:  1999-05

Review 3.  A survey of medical image registration.

Authors:  J B Maintz; M A Viergever
Journal:  Med Image Anal       Date:  1998-03       Impact factor: 8.545

4.  The new technology of combined transmission and emission tomography in evaluation of endocrine neoplasms.

Authors:  E Even-Sapir; Z Keidar; J Sachs; A Engel; L Bettman; D Gaitini; L Guralnik; N Werbin; G Iosilevsky; O Israel
Journal:  J Nucl Med       Date:  2001-07       Impact factor: 10.057

5.  [Surgical and adjuvant therapy of neuroendocrine tumors of the gastrointestinal tract and their metastases. A retrospective analysis of personal patient group].

Authors:  S Schmidbauer; R Ladurner; H Jückstock; A W Trupka; T Mussack; K K Hallfeldt
Journal:  Chirurg       Date:  2001-08       Impact factor: 0.955

Review 6.  [Classification of neuroendocrine tumors of the gastrointestinal tract and pancreas and its therapeutic relevance].

Authors:  H Höfler; A Stier; V Schusdziarra; J R Siewert
Journal:  Chirurg       Date:  1997-02       Impact factor: 0.955

Review 7.  Preoperative diagnosis and surgical management of neuroendocrine gastroenteropancreatic tumors: general recommendations by a consensus workshop.

Authors:  B Wiedenmann; R T Jensen; M Mignon; C I Modlin; B Skogseid; G Doherty; K Oberg
Journal:  World J Surg       Date:  1998-03       Impact factor: 3.352

8.  [Fusion of CT and PET data: methods and clinical relevance for planning laser-induced thermotherapy of liver metastases].

Authors:  N Hosten; R Kreissig; R Puls; H Amthauer; J Beier; T Rohlfing; C Stroszczynski; A Herbel; A J Lemke; R Felix
Journal:  Rofo       Date:  2000-07

9.  An analysis of 8305 cases of carcinoid tumors.

Authors:  I M Modlin; A Sandor
Journal:  Cancer       Date:  1997-02-15       Impact factor: 6.860

Review 10.  Somatostatin receptor scintigraphy with [111In-DTPA-D-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients.

Authors:  E P Krenning; D J Kwekkeboom; W H Bakker; W A Breeman; P P Kooij; H Y Oei; M van Hagen; P T Postema; M de Jong; J C Reubi
Journal:  Eur J Nucl Med       Date:  1993-08
View more
  6 in total

1.  99mTc-EDDA/HYNIC-octreotate scintigraphy, an efficient method for the detection and staging of carcinoid tumours: results of 3 years' experience.

Authors:  A Hubalewska-Dydejczyk; K Fröss-Baron; R Mikołajczak; H R Maecke; B Huszno; D Pach; A Sowa-Staszczak; B Janota; P Szybiński; J Kulig
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-05-24       Impact factor: 9.236

2.  Image fusion analysis of (99m)Tc-HYNIC-Tyr(3)-octreotide SPECT and diagnostic CT using an immobilisation device with external markers in patients with endocrine tumours.

Authors:  Michael Gabriel; Florian Hausler; Reto Bale; Roy Moncayo; Clemens Decristoforo; Peter Kovacs; Irene Virgolini
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-08-26       Impact factor: 9.236

3.  Fusion imaging using a hybrid SPECT-CT camera improves port perfusion scintigraphy for control of hepatic arterial infusion of chemotherapy in colorectal cancer patients.

Authors:  Timm Denecke; Bert Hildebrandt; Lukas Lehmkuhl; Nils Peters; Annett Nicolaou; Maciej Pech; Hanno Riess; Jens Ricke; Roland Felix; Holger Amthauer
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-04-22       Impact factor: 9.236

4.  Evaluation of the potential of PET-MRI fusion for detection of liver metastases in patients with neuroendocrine tumours.

Authors:  Nils F Schreiter; Munenobu Nogami; Ingo Steffen; Ulrich-Frank Pape; Bernd Hamm; Winfried Brenner; Rainer Röttgen
Journal:  Eur Radiol       Date:  2011-09-09       Impact factor: 5.315

5.  Value of image fusion using single photon emission computed tomography with integrated low dose computed tomography in comparison with a retrospective voxel-based method in neuroendocrine tumours.

Authors:  H Amthauer; T Denecke; T Rohlfing; J Ruf; M Böhmig; M Gutberlet; U Plöckinger; R Felix; A J Lemke
Journal:  Eur Radiol       Date:  2004-12-31       Impact factor: 5.315

6.  Automatic and manual image fusion of In-pentetreotide SPECT and diagnostic CT in neuroendocrine tumor imaging - An evaluation.

Authors:  Elisabeth Hedlund; Jan-Erik Karlsson; Sven-Åke Starck
Journal:  J Med Phys       Date:  2010-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.